Literature DB >> 14645699

Inverse correlation between high level expression of cyclin E and proliferation index in transitional cell carcinoma of the bladder.

A A Khan1, P D Abel, K S Chaudhary, Z Gulzar, G W H Stamp, E-N Lalani.   

Abstract

BACKGROUND/AIMS: Overexpression of the G1 cyclins, D1 and E, and/or downregulation of p27(Kip1) allow uncontrolled tumour cell proliferation. This study investigated the relation between these three cell cycle proteins and tumour proliferation in bladder cancer.
METHOD: Nuclear expression of cyclin D1, cyclin E, and p27(Kip1) was determined immunohistochemically in 52 primary transitional cell carcinomas, and the Ki-67 proliferation marker was also assessed. For each protein, the percentage of positive tumour cell nuclei was determined and analysed as a continuous variable.
RESULTS: Advancing tumour grade and pathological stage were accompanied by increasing proliferation indices, but decreasing p27(Kip1) and cyclin D1 expression, with no significant change in cyclin E expression. Overall, cyclin D1 and E expression did not correlate with proliferation. However, in cyclin D1 overexpressing tumours (> or = 5% nuclei positive), the level of cyclin D1 expression positively correlated with proliferation. The correlation between cyclin E expression and proliferation changed from positive to negative with increasing levels of cyclin E expression, accompanied by a coordinate increase in p27(Kip1) expression. Overall, there was an inverse association between p27(Kip1) expression and proliferation. However, a subset of tumours displayed high proliferation indices despite high p27(Kip1) expression. The G1 cyclin index (sum of the level of expression of cyclins D1 and E) correlated positively with proliferation in superficial but not muscle invasive tumours. This correlation was stronger when the G1 cyclin index was adjusted for p27(Kip1) expression.
CONCLUSION: These findings support a role for these proteins in the proliferation, differentiation, and progression of bladder transitional cell carcinomas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645699      PMCID: PMC1187355          DOI: 10.1136/mp.56.6.353

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  48 in total

1.  Expression of p27(kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas: the emerging role of p27(kip) in malignant transformation of neurofibromas.

Authors:  H P Kourea; C Cordon-Cardo; M Dudas; D Leung; J M Woodruff
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (G0 state) in fibroblasts.

Authors:  N Rivard; G L'Allemain; J Bartek; J Pouysségur
Journal:  J Biol Chem       Date:  1996-08-02       Impact factor: 5.157

3.  Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival.

Authors:  J J Del Pizzo; A Borkowski; S C Jacobs; N Kyprianou
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

4.  Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.

Authors:  I Reynisdóttir; K Polyak; A Iavarone; J Massagué
Journal:  Genes Dev       Date:  1995-08-01       Impact factor: 11.361

5.  Overexpression of cyclin E in the HC11 mouse mammary epithelial cell line is associated with growth inhibition and increased expression of p27(Kip1).

Authors:  A Sgambato; E K Han; P Zhou; I Schieren; I B Weinstein
Journal:  Cancer Res       Date:  1996-03-15       Impact factor: 12.701

6.  Expression of retinoblastoma gene product and p53 protein in bladder carcinoma: correlation with Ki67 index.

Authors:  C Wright; D Thomas; K Mellon; D E Neal; C H Horne
Journal:  Br J Urol       Date:  1995-02

7.  Human cyclin E, a nuclear protein essential for the G1-to-S phase transition.

Authors:  M Ohtsubo; A M Theodoras; J Schumacher; J M Roberts; M Pagano
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

8.  Cyclins as markers of tumor proliferation: immunocytochemical studies in breast cancer.

Authors:  A Dutta; R Chandra; L M Leiter; S Lester
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

9.  Different roles for cyclins D1 and E in regulation of the G1-to-S transition.

Authors:  D Resnitzky; S I Reed
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

Review 10.  Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia.

Authors:  C Cordon-Cardo
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

View more
  4 in total

1.  Anticancer properties of novel aminoacetonitrile derivative monepantel (ADD 1566) in pre-clinical models of human ovarian cancer.

Authors:  Farnaz Bahrami; David L Morris; Lucien Rufener; Mohammad H Pourgholami
Journal:  Am J Cancer Res       Date:  2014-09-06       Impact factor: 6.166

2.  Differential expression of cell cycle regulators in HCV-infection and related hepatocellular carcinoma.

Authors:  Azza E El Bassiouny; Mona M Nosseir; Mona K Zoheiry; Noha A Ameen; Ahmed M Abdel-Hadi; Ibrahim M Ibrahim; Suher Zada; Abdel-Hakeem Saad El-Deen; Nora E El-Bassiouni
Journal:  World J Hepatol       Date:  2010-01-27

3.  Loss of p27 upregulates MnSOD in a STAT3-dependent manner, disrupts intracellular redox activity and enhances cell migration.

Authors:  Dongyun Zhang; Yulei Wang; Yuguang Liang; Min Zhang; Jinlong Wei; Xiao Zheng; Fei Li; Yan Meng; Nina Wu Zhu; Jingxia Li; Xue-Ru Wu; Chuanshu Huang
Journal:  J Cell Sci       Date:  2014-04-11       Impact factor: 5.285

4.  Prognostic significance of P27 (Kip 1) and MUC1 in papillary transitional cell carcinoma of the urinary bladder.

Authors:  Taghreed A Abd Elazeez; Abd El-Latef M El-Balshy; Mostafa M Khalil; Magdy M El-Tabye; Hamdy Abdul-Halim
Journal:  Urol Ann       Date:  2011-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.